Luteinizing hormone-releasing hormone agonist
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Luteinizing hormone-releasing hormone agonist, covering 2017-03-21 to 2017-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer [Phase 1]